BMT Tandem 2018

As a global leader in drug development, Sarah Cannon has made countless contributions to advancing cancer therapies for more than two decades. Our blood cancer research experts will highlight the latest developments in hematopoietic stem cell transplantation through 18 presentations at the 2018 BMT Tandem Meetings. Visit Sarah Cannon at Booth #107.

View Presentation Schedule

About The Sarah Cannon Blood Cancer Network

Sarah Cannon brings together physician-led blood cancer programs across the United States and United Kingdom to offer patients convenient access to care including hematopoietic cell transplantation (HCT) and clinical trials. The Sarah Cannon Blood Cancer Network is one of the largest providers of hematopoietic cell transplantation (HCT). It conducts more than 1,000 transplants annually through six FACT accredited transplant centers, and has completed over 14,000 transplants since the inception of its first program.

The Sarah Cannon Blood Cancer Network programs include St. David’s South Austin Medical Center in Austin, TX, Medical City Dallas Hospital in Dallas, TX, Colorado Blood Cancer Institute at Presbyterian/St. Luke’s Medical Center- HealthONE in Denver, Colo., HCA Midwest Health- Research Medical Center, in Kansas City, Mo., Sarah Cannon Center for Blood Cancer at TriStar Centennial Medical Center in Nashville, Tenn., Tulane Medical Center in New Orleans, La., Texas Transplant Institute at Methodist Hospital in San Antonio, TX, Harley Street at UCH in London and The Christie Clinic in Manchester, England.

For more information about the Network and Sarah Cannon’s full suite of oncology services, visit

Media Contacts

Sarah Cannon physicians and leadership are available for interview at the 2018 BMT Tandem Meetings. Please contact the below regarding media opportunities.

Samantha Maxwell